Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis
Authors
Keywords
Esophageal squamous cell carcinoma, Aquaporin 3, Aquaporin 5, Clinicopathology, Prognosis
Journal
MEDICAL ONCOLOGY
Volume 30, Issue 3, Pages -
Publisher
Springer Nature America, Inc
Online
2013-06-24
DOI
10.1007/s12032-013-0636-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PIK3CA Mutation Is Associated with a Favorable Prognosis among Patients with Curatively Resected Esophageal Squamous Cell Carcinoma
- (2013) H. Shigaki et al. CLINICAL CANCER RESEARCH
- The expression and distribution of aquaporin 3 in mouse embryos before and after vitrification
- (2013) Ying-qi Nong et al. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
- Hypoxia and Hypoxia Mimetics Decrease Aquaporin 5 (AQP5) Expression through Both Hypoxia Inducible Factor-1α and Proteasome-Mediated Pathways
- (2013) Jitesh D. Kawedia et al. PLoS One
- The Gating Mechanism of the Human Aquaporin 5 Revealed by Molecular Dynamics Simulations
- (2013) Lorant Janosi et al. PLoS One
- Tumor length in elderly patients with esophageal squamous cell carcinoma: Is it a prognostic factor?
- (2013) Ji-Feng Feng et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Function of the Membrane Water Channel Aquaporin-5 in the Salivary Gland
- (2012) Toshiyuki Matsuzaki et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- Aquaporins in drug discovery and pharmacotherapy
- (2012) Vincent J. Huber et al. MOLECULAR ASPECTS OF MEDICINE
- The Expression of High Mobility Group Box 1 is Associated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma
- (2012) Chen Chuangui et al. PATHOLOGY & ONCOLOGY RESEARCH
- High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis
- (2012) Jian-Hua Wang et al. PLoS One
- Aquaporins in Clinical Medicine
- (2011) A.S. Verkman Annual Review of Medicine
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma
- (2011) Morio Kusayama et al. CANCER SCIENCE
- Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma
- (2011) J.J. Xie et al. EJSO
- Hepatocyte aquaporins in bile formation and cholestasis
- (2011) Raul Alberto Marinelli Frontiers in Bioscience-Landmark
- Aquaporins at a glance
- (2011) A. S. Verkman JOURNAL OF CELL SCIENCE
- Overexpression of AQP5 in cervical cancer: correlation with clinicopathological features and prognosis
- (2011) Ting Zhang et al. MEDICAL ONCOLOGY
- Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance
- (2010) Lizong Shen et al. BIOMEDICINE & PHARMACOTHERAPY
- Critical role of aquaporin-3 in the human epidermal growth factor-induced migration and proliferation in the human gastric adenocarcinoma cells
- (2010) Yiming Huang et al. CANCER BIOLOGY & THERAPY
- Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer
- (2010) Ziqiang Zhang et al. JOURNAL OF PATHOLOGY
- Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy
- (2009) M Ismail et al. BRITISH JOURNAL OF CANCER
- Involvement of aquaporin-5 in differentiation of human gastric cancer cells
- (2009) Tomoko Watanabe et al. Journal of Physiological Sciences
- Role of Human Aquaporin 5 In Colorectal Carcinogenesis
- (2008) Sung Koo Kang et al. AMERICAN JOURNAL OF PATHOLOGY
- Overexpression of AQP5, a putative oncogene, promotes cell growth and transformation
- (2008) Janghee Woo et al. CANCER LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started